483
Charles River Laboratories, Inc.FDA 483 - Charles River Laboratories, Inc. - March 21, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Charles River Laboratories, Inc. in Reno, NV, a nonclinical laboratory, revealed significant deficiencies in their study documentation and reporting practices. The firm failed to accurately record experimental data, ensure protocols contained all necessary details, and include complete descriptions of methods and test systems in final study reports. These issues suggest a lack of adherence to Good Laboratory Practice regulations.
Open in Dashboard
ID · 9be60eba-6ad6-42ac-96d9-d1ebdf6c2f11